The old-school model of a medical device manufacturing supply chain is being challenged, with the rise of competition and increased competition. Todd Martensen, former COO with Ascential Medical & Life Sciences, argues that the use of technology to streamline and streamline the various stages of device development and regulatory approval is a crucial opportunity. Automation can be applied to discrete processes such as placing an active ingredient within a catheter, which allows for more precision and lower cost, and can be built into the various inspection steps essential for product design, verification and development. However, there is a potential for resistance to automation at the regulatory approval stage due to a shortage of labor and high cost of labor. As a result, manufacturers may face pushback from current labor force due to the shift towards higher-skilled North American labor.
Source
This post was brought to you by Wrk. Our bot looks for news related to automation and post daily.
